Compounds > iomeprol
Page last updated: 2024-10-29

iomeprol and Basal Ganglia Diseases

iomeprol has been researched along with Basal Ganglia Diseases in 1 studies

iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schwarz, M1
Engelhorn, T1
Eyupoglu, IY1
Brünner, H1
Struffert, T1
Kalender, W1
Dörfler, A1

Other Studies

1 other study available for iomeprol and Basal Ganglia Diseases

ArticleYear
In vivo imaging of MSCT and micro-CT: a comparison.
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2010, Volume: 182, Issue:4

    Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Brain Neoplasms; Cell Line, Tumor; Contrast Media; G

2010